Related Experiment Video
Updated: Jun 6, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells
Natsumi Kubo1, Rintaro Okoshi, Kumiko Nakashima
1Laboratory of Anti-tumor Research, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.
Abstract:
It has been shown that MDM2 inhibits the transcriptional and pro-apoptotic activities of p73 but does not promote its proteasomal degradation. In this study, we found that MDM2 indirectly induces the degradation of p73 through the interaction with Itch in HeLa cells. During adriamycin (ADR)-mediated apoptosis, p53 and p73 were induced to stabilize in association with a significant reduction of MDM2 and Itch, suggesting that, in addition to Itch, MDM2 could also be involved in the stability control of p73. As expected, forced expression of MDM2 resulted in a remarkable reduction of p73. MDM2-mediated degradation of p73 was inhibited by MG-132. Intriguingly, siRNA-mediated knockdown of Itch significantly attenuated the negative effect of MDM2 on p73. Additionally, MDM2 bound to Itch in HeLa cells but not in H1299 cells. Collectively, our present findings suggest that MDM2 promotes Itch-mediated degradation of p73 through the interaction with Itch in HeLa cells.
Insights
MDM2 targets the tumor suppressor p73 for degradation indirectly via Itch. This interaction, observed in HeLa cells, reveals a novel mechanism controlling p73 stability during apoptosis and cancer research.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- MDM2 is known to inhibit p73's transcriptional and pro-apoptotic functions.
- Previous understanding did not include MDM2's role in p73's proteasomal degradation.
Purpose of the Study:
- To investigate the mechanism by which MDM2 affects p73 stability.
- To explore the role of Itch in the MDM2-p73 interaction.
Main Methods:
- Utilized HeLa and H1299 cell lines.
- Employed siRNA-mediated knockdown of Itch.
- Applied proteasome inhibitor MG-132.
- Performed co-immunoprecipitation to assess protein interactions.
Main Results:
- MDM2 indirectly induces p73 degradation through interaction with Itch in HeLa cells.
- MDM2 and Itch levels decreased during adriamycin-induced apoptosis, correlating with p53 and p73 stabilization.
- Knockdown of Itch attenuated MDM2's negative impact on p73.
- MDM2 directly bound to Itch specifically in HeLa cells.
Conclusions:
- MDM2 promotes Itch-mediated degradation of p73.
- This interaction is cell-type specific and occurs in HeLa cells.
- MDM2 influences p73 stability through a novel indirect pathway involving Itch.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
Export of Misfolded Proteins out of the ER
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle